Latest News
Scienture Holdings, Inc.
- Scienture Holdings Well Positioned to Deliver Continued Sequential Rev Growth >SCNX
- Scienture reports Q3 revenue of $1.22 million, up 256% sequentially By Investing.com
- Scienture reports 256% revenue jump in Q3 on two FDA products
- Scienture Holdings Regains Nasdaq Compliance Amid Revenue Surge
- Scienture Holdings Q3FY26 Results: Revenue soars 256% to $1.22 million
- SCIENTURE Reports Approximately $1.22 Million in Unaudited Preliminary Q3 2026 Revenue, Achieving 256% Sequential Growth
- EXCLUSIVE: Scienture Revenue Soars 256% As Drugmaker Targets 2027 Profitability
- Scienture Holdings, Inc. Reports Preliminary, Unaudited Revenue Results for the Third Quarter Ended September 30, 2026
- Scienture reports $1.22M Q3 revenue, up 256% se...
- Scienture Holdings (SCNX) Ticks Higher as Shares Close at $3.81, Up 1.33% - Equal Weight ETF
- Scienture Holdings, Inc. Announces Reverse Stock Split
- Scienture Holdings Announces Reverse Stock Split
Headlines from the last 30 days, linking to the original publishers. See all market news →